These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33369667)

  • 1. Preliminary evidence on abatacept safety and efficacy in refractory juvenile localized scleroderma.
    Li SC; Torok KS; Ishaq SS; Buckley M; Edelheit B; Ede KC; Liu C; Rabinovich CE
    Rheumatology (Oxford); 2021 Aug; 60(8):3817-3825. PubMed ID: 33369667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma.
    Martini G; Saggioro L; Culpo R; Vittadello F; Meneghel A; Zulian F
    Rheumatology (Oxford); 2021 Mar; 60(3):1387-1391. PubMed ID: 32978631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the Systemic Treatment of Pediatric Localized Scleroderma.
    Foeldvari I
    Paediatr Drugs; 2019 Dec; 21(6):461-467. PubMed ID: 31667717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil.
    Martini G; Ramanan AV; Falcini F; Girschick H; Goldsmith DP; Zulian F
    Rheumatology (Oxford); 2009 Nov; 48(11):1410-3. PubMed ID: 19713439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study.
    Li SC; Fuhlbrigge RC; Laxer RM; Pope E; Ibarra MF; Stewart K; Mason T; Becker ML; Hong S; Dedeoglu F; Torok KS; Rabinovich CE; Ferguson PJ; Punaro M; Feldman BM; Andrews T; Higgins GC;
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):43. PubMed ID: 31307476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early- and late-stage morphea subtypes with deep tissue involvement is treatable with Abatacept (Orencia).
    Adeeb F; Anjum S; Hodnett P; Kashif A; Brady M; Morrissey S; Devlin J; Fraser AD
    Semin Arthritis Rheum; 2017 Jun; 46(6):775-781. PubMed ID: 27773434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment in Juvenile Scleroderma.
    Zulian F; Tirelli F
    Curr Rheumatol Rep; 2020 Jun; 22(8):45. PubMed ID: 32591919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in juvenile systemic and localized scleroderma.
    Foeldvari I
    Rheum Dis Clin North Am; 2013 Nov; 39(4):905-20. PubMed ID: 24182860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abatacept in the treatment of localized scleroderma: A pediatric case series and systematic literature review.
    Kalampokis I; Yi BY; Smidt AC
    Semin Arthritis Rheum; 2020 Aug; 50(4):645-656. PubMed ID: 32504991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracutaneous involvement is common and associated with prolonged disease activity and greater impact in juvenile localized scleroderma.
    Li SC; Higgins GC; Chen M; Torok KS; Rabinovich CE; Stewart K; Laxer RM; Pope E; Haines KA; Punaro M; O'Neil KM;
    Rheumatology (Oxford); 2021 Dec; 60(12):5724-5733. PubMed ID: 33711155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial.
    Zulian F; Martini G; Vallongo C; Vittadello F; Falcini F; Patrizi A; Alessio M; La Torre F; Podda RA; Gerloni V; Cutrone M; Belloni-Fortina A; Paradisi M; Martino S; Perilongo G
    Arthritis Rheum; 2011 Jul; 63(7):1998-2006. PubMed ID: 21305525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-centre national audit of juvenile localised scleroderma: describing current UK practice in disease assessment and management.
    Lythgoe H; Almeida B; Bennett J; Bhat C; Bilkhu A; Brennan M; Deepak S; Dawson P; Eleftheriou D; Harrison K; Hawley D; Heaf E; Leone V; Long E; Maltby S; McErlane F; Rafiq N; Ramanan AV; Riley P; Rangaraj S; Varnier G; Wilkinson N; Pain CE
    Pediatr Rheumatol Online J; 2018 Dec; 16(1):80. PubMed ID: 30563543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic therapy in juvenile localized scleroderma.
    Foeldvari I; Marrani E
    Expert Rev Clin Immunol; 2023; 19(10):1225-1238. PubMed ID: 37462119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study about evaluation of efficacy of methotrexate in localized scleroderma using ultrasonography.
    Zhang F; Li J; Zhao Q; Liu H; Zhang F
    Skin Res Technol; 2023 Mar; 29(3):e13300. PubMed ID: 36973989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esophageal abnormalities in juvenile localized scleroderma: is it associated with other extracutaneous manifestations?
    Valões CCM; Novak GV; Brunelli JB; Kozu KT; Toma RK; Silva CA
    Rev Bras Reumatol Engl Ed; 2017; 57(6):521-525. PubMed ID: 29173689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review.
    Soh HJ; Samuel C; Heaton V; Renton WD; Cox A; Munro J
    Rheumatol Int; 2019 May; 39(5):933-941. PubMed ID: 30838436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT.
    Brown S; Everett CC; Naraghi K; Davies C; Dawkins B; Hulme C; McCabe C; Pavitt S; Emery P; Sharples L; Buch MH
    Health Technol Assess; 2018 Jun; 22(34):1-280. PubMed ID: 29900829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil and Mycophenolic Acid for the Treatment of Morphea.
    Arthur M; Fett NM; Latour E; Jacobe H; Kunzler E; Florez-Pollack S; Houser J; Sharma S; Prasad S; Femia A; Stern MJ; Pappas-Taffer LK; Gaffney R; Fernandez AP; Knabel D; Cardones AR; Leung N; Laumann A; Yu JM; Zhao J; Vleugels RA; Tkachenko E; Lo K
    JAMA Dermatol; 2020 May; 156(5):521-528. PubMed ID: 32236497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation.
    Shepherd J; Cooper K; Harris P; Picot J; Rose M
    Health Technol Assess; 2016 Apr; 20(34):1-222. PubMed ID: 27135404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea).
    Zulian F; Vallongo C; Patrizi A; Belloni-Fortina A; Cutrone M; Alessio M; Martino S; Gerloni V; Vittadello F; Martini G
    J Am Acad Dermatol; 2012 Dec; 67(6):1151-6. PubMed ID: 22657157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.